Brain Aspergillosis: Impact of Azole Therapy

P. TATTEVIN, F. BRUNEEL, F. LELLOUCHE, T. DE BROUCKER, S. CHEVRET, M. WOLFF, B. REGNIER

Author address: 

Infectious Diseases ICU, Hôpital Bichat-Claude Bernard, Paris, France.

Abstract: 

Background: In patients with invasive aspergillosis (IA), central nervous system involvement is one of the most succesful predictive factor of therapeutic failure. With standard or liposomal amphotericin B (amB), the rate of complete response is
2002

abstract No: 

M-869

Full conference title: 

42nd Interscience Conference on Antimicrobial Agents and Chemotherapy
    • ICAAC 42nd